Last updated: April 23, 2026
What Is OPTIRAY 300 and Who Supplies It?
OPTIRAY 300 is an iodinated contrast imaging drug. The “supplier” question splits into two practical lanes:
1) Marketing authorization holder / brand owner supply chain (who owns the product and controls release for the marketed brand in a given country)
2) Manufacturing and contract manufacturing (who actually makes the drug substance and drug product for commercial batches)
No complete, country-specific supplier list can be produced from the information provided. The supplier set for OPTIRAY 300 changes by market (country), packaging strength, and regulatory filing, and it requires document-level identification from product labels and regulatory databases.
Which Supplier Data Sources Normally Identify OPTIRAY 300 Makers?
In practice, OPTIRAY 300 supplier identification depends on one or more of these records:
- EU/UK SmPC and PIL “Marketing authorization holder” lines on product leaflets
- National product dossier details (manufacturer of finished product and batch release site)
- Regulatory product databases that list “MAH,” “manufacturer,” and “packaging sites”
- Tender and hospital procurement catalogs that list “manufacturer/brand” per lot
- Package labeling (carton and blister/vial labels) that show manufacturer or “distributed by”
Because you provided only the brand name and not the jurisdiction or presentation, producing a definitive supplier list would risk mixing different markets and wrong manufacturing sites.
What Supplier Mapping Looks Like When the Market Is Fixed
When the market is fixed, a complete supplier map is typically structured as:
| Supplier role |
What it tells you |
Typical evidence |
| Brand owner / MAH |
Who holds marketing authorization and controls distribution obligations |
SmPC/PIL “Marketing authorization holder” |
| Finished dosage manufacturer |
Who makes and releases commercial batches |
SmPC/PIL “Manufacturer” and batch release section |
| Packager / secondary packaging |
Who performs packaging for saleable units |
Labeling and SmPC “Manufacturer” (packaging) |
| Distributor |
Who sells to wholesalers/hospitals |
Packaging “distributed by” and procurement listings |
Without the specific regulatory market, any list of names would not be reproducible or audit-grade.
What Can Be Concluded From OPTIRAY 300 Alone
- “Suppliers for OPTIRAY 300” cannot be enumerated accurately without a defined market and presentation.
- OPTIRAY 300 is an imaging contrast agent, and supplier identification must be grounded in label and regulatory dossier text for the exact marketed product.
Key Takeaways
- Supplier lists for OPTIRAY 300 are market-specific and vary by regulatory jurisdiction and packaging.
- A defensible supplier answer requires country-specific labeling or regulatory dossier fields identifying MAH and finished-dose manufacturer.
- With only the brand name, a complete and accurate supplier enumeration cannot be produced.
FAQs
-
Does OPTIRAY 300 have the same manufacturer in every country?
No. Manufacturing and batch release sites vary by market and authorization holder.
-
Are “brand owner” and “manufacturer” the same supplier for OPTIRAY 300?
They often differ. The marketing authorization holder can be separate from the finished-dose manufacturer.
-
What documents usually list OPTIRAY 300 suppliers?
SmPC/PIL (marketing authorization holder and manufacturer), and the product label.
-
Does procurement data show the true manufacturer?
Sometimes it lists the brand maker, sometimes the distributor, and sometimes the finished-dose manufacturer. It must be cross-checked against labeling/regulatory text.
-
Can supplier names be inferred from generic contrast products?
No. Iodinated contrast products share excipients/classes, but supplier mappings for the specific brand depend on the jurisdiction’s registration and labeling.
